Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Can J Gastroenterol (2012) 3.15

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 2.28

A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology (2014) 2.00

Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf (2011) 1.76

Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology (2015) 1.69

Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Dig Dis Sci (2012) 1.66

AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology (2013) 1.64

ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol (2015) 1.58

Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol (2013) 1.55

Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology (2010) 1.52

Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47

Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding. Hepatology (2016) 1.39

Treatment of portal hypertension. World J Gastroenterol (2012) 1.39

Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysis. World J Gastroenterol (2014) 1.35

Therapy for alcoholic liver disease. World J Gastroenterol (2014) 1.17

Management of gastropathy and gastric vascular ectasia in portal hypertension. Clin Liver Dis (2010) 1.09

Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol (2012) 1.08

Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: The special Egyptian situation: Noninvasive prediction of esophageal varices. Hepat Mon (2011) 1.06

Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia. Dig Dis Sci (2011) 1.06

Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int (2011) 1.04

Therapeutic endoscopy for acute upper gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol (2010) 1.02

Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol (2012) 1.02

Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis. World J Gastroenterol (2016) 1.02

Non-alcoholic fatty liver disease: a practical approach to treatment. Frontline Gastroenterol (2014) 1.01

Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol (2014) 1.00

Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2012) 0.99

Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99

The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions. Surg Endosc (2011) 0.98

Long-term result of endoscopic Histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol (2011) 0.98

Balloon-occluded retrograde transvenous obliteration for gastric varices: the relationship between the clinical outcome and gastrorenal shunt occlusion. BMC Med Imaging (2010) 0.98

Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96

Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol (2015) 0.94

Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr (2013) 0.93

Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique. Radiology (2014) 0.92

Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92

Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib. PLoS One (2011) 0.92

Complete esophageal obstruction following endoscopic variceal ligation. Gastroenterol Hepatol (N Y) (2011) 0.92

Predictors of a variceal source among patients presenting with upper gastrointestinal bleeding. Can J Gastroenterol (2012) 0.92

The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: pilot study. Saudi J Gastroenterol (2013) 0.91

Adherence and adequacy of therapy for esophageal varices prophylaxis. Dig Dis Sci (2011) 0.90

Value of transient elastography for the prediction of variceal bleeding. World J Gastroenterol (2011) 0.90

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data. Clin Mol Hepatol (2014) 0.90

Evaluation and management of patients with refractory ascites. World J Gastroenterol (2009) 0.89

Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study. Gastroenterol Res Pract (2015) 0.89

Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond. World J Gastroenterol (2014) 0.89

Upper gastrointestinal bleeding etiology score for predicting variceal and non-variceal bleeding. World J Gastroenterol (2009) 0.89

Management of liver cirrhosis between primary care and specialists. World J Gastroenterol (2011) 0.89

Variceal hemorrhage: Saudi tertiary center experience of clinical presentations, complications and mortality. World J Hepatol (2012) 0.89

Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol (2014) 0.88

Pregnancy with portal hypertension. J Clin Exp Hepatol (2014) 0.88

Pregnancy and vascular liver disease. J Clin Exp Hepatol (2015) 0.88

A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm. Int J Hepatol (2011) 0.88

Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis. J Gastroenterol (2013) 0.87

Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data. Clin Mol Hepatol (2013) 0.87

Pathophysiology of portal hypertension and esophageal varices. Int J Hepatol (2012) 0.87

Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Clin Mol Hepatol (2015) 0.87

A new candidate as a hemostatic agent for difficult situations during variceal bleeding: Ankaferd blood stopper. Saudi J Gastroenterol (2011) 0.87

The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage. PLoS One (2013) 0.87

Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87

Endoscopic management of gastric variceal bleeding with cyanoacrylate glue injection: safety and efficacy in a Canadian population. Can J Gastroenterol (2010) 0.87

The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol (2009) 0.86

Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol (2015) 0.86

Portal hypertensive enteropathy. World J Hepatol (2015) 0.86

Improving survival in decompensated cirrhosis. Int J Hepatol (2012) 0.86

Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine prehepatic portal hypertension. Am J Physiol Gastrointest Liver Physiol (2008) 0.86

Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis. World J Hepatol (2014) 0.86

Self-expandable metal stents in the treatment of acute esophageal variceal bleeding. Gastroenterol Res Pract (2011) 0.86

Gluing gastric varices in 2012: lessons learnt over 25 years. J Clin Exp Hepatol (2012) 0.86

Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies. Hepatology (2013) 0.86

Clinical outcomes of gastric variceal obliteration using N-butyl-2-cyanoacrylate in patients with acute gastric variceal hemorrhage. Korean J Intern Med (2014) 0.86

Comparison between endoscopic sclerotherapy and band ligation for hemostasis of acute variceal bleeding. World J Gastrointest Endosc (2011) 0.85

Study of liver cirrhosis over ten consecutive years in Southern China. World J Gastroenterol (2014) 0.85

Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study. Clin Mol Hepatol (2012) 0.85

Primary prophylaxis of variceal bleeding. Gastroenterol Hepatol (N Y) (2011) 0.85

Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol (2013) 0.85

Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol (2011) 0.85

Update on the management of cirrhosis - focus on cost-effective preventative strategies. Clinicoecon Outcomes Res (2013) 0.84

Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clin Transl Gastroenterol (2015) 0.84

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis. PLoS One (2015) 0.84

Variceal band ligation in the prevention of variceal bleeding: a multicenter trial. Saudi J Gastroenterol (2011) 0.84

Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage. Int J Hepatol (2011) 0.84

Transjugular intrahepatic portosystemic shunt. Clin Liver Dis (2014) 0.84

A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease. Clin Mol Hepatol (2012) 0.84

Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosis. Dig Dis Sci (2015) 0.84

Prediction of large esophageal varices in cirrhotic patients using classification and regression tree analysis. Clinics (Sao Paulo) (2011) 0.84

Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr (2011) 0.84

Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol (2011) 0.84

Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol (2014) 0.84

Accuracy of transnasal endoscopy with a disposable esophagoscope compared to conventional endoscopy. World J Gastrointest Endosc (2014) 0.83

The effect of weekend versus weekday admission on outcomes of esophageal variceal hemorrhage. Can J Gastroenterol (2009) 0.83

Doppler surrogate endoscopy for screening esophageal varices in patients with cirrhosis. Hepat Mon (2014) 0.83

Current Management Strategies for Acute Esophageal Variceal Hemorrhage. Curr Hepatol Rep (2014) 0.83

Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis. World J Gastroenterol (2015) 0.83

Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study. Med Sci Monit (2015) 0.82

Risk factors for predicting early variceal rebleeding after endoscopic variceal ligation. World J Gastroenterol (2011) 0.82

Endoscopic ultrasound (EUS)-guided coil injection therapy of esophagogastric and ectopic varices. Surg Endosc (2015) 0.82

Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ (2012) 0.82

Esophageal variceal ligation in the secondary prevention of variceal bleeding: Result of long term follow-up. Pan Afr Med J (2013) 0.81

Endoscopic Diagnosis and Therapy in Gastroesophageal Variceal Bleeding. Gastrointest Endosc Clin N Am (2015) 0.81

Update of endoscopy in liver disease: more than just treating varices. World J Gastroenterol (2012) 0.81

Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology (2012) 11.03

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol (2008) 7.94

American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol (2007) 7.49

Practice guidelines in acute pancreatitis. Am J Gastroenterol (2006) 7.05

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med (2005) 6.31

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology (2012) 5.47

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (2010) 5.20

Alcoholic liver disease. Hepatology (2010) 5.04

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology (2003) 4.69

Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med (2008) 4.07

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol (2002) 3.94

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology (2008) 3.68

A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology (2007) 3.65

Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (2004) 3.63

The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol (2013) 3.51

The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology (2009) 3.48

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology (2004) 3.45

ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol (2014) 3.43

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA (2011) 3.37

Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology (2007) 3.06

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology (2011) 2.97

The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology (2007) 2.94

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86

Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. Gastroenterology (2013) 2.82

Sepsis-induced cholestasis. Hepatology (2007) 2.80

Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol (2009) 2.73

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology (2013) 2.70

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2009) 2.42

Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology (2009) 2.40

Guidelines for the management of dyspepsia. Am J Gastroenterol (2005) 2.39

Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology (2003) 2.38

The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol (2011) 2.37

Hepatic Encephalopathy. Am J Gastroenterol (2001) 2.37

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl (2002) 2.25

Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion (2007) 2.19

An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 2.18

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemp Clin Trials (2008) 2.17

Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol (2010) 2.16

Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology (2009) 2.16

Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology (2008) 2.10

Management of Crohn's disease in adults. Am J Gastroenterol (2001) 2.09

Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology (2012) 2.01

Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr (2007) 1.99

ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol (2007) 1.98

Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab (2012) 1.97

Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective. Am J Gastroenterol (2009) 1.93

The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology (2013) 1.92

Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha. Hepatology (2007) 1.90

Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (2014) 1.89

Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol (2007) 1.87

Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology (2012) 1.86

MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl (2007) 1.86

Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol (2011) 1.85

Cirrhotic cardiomyopathy. J Am Coll Cardiol (2010) 1.77

Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl (2004) 1.76

Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int (2009) 1.76

Utilization of and adherence to the gastroenterology core curriculum on hepatology training during a gastrointestinal fellowship. Clin Gastroenterol Hepatol (2008) 1.72

Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol (2012) 1.70

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology (2011) 1.63

The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol (2012) 1.61

Portal hypertensive bleeding. Gastroenterol Clin North Am (2003) 1.60

Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver Int (2009) 1.59

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology (2010) 1.58

Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology (2010) 1.55

Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology (2010) 1.52

Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol (2010) 1.52

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One (2013) 1.51

Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology (2006) 1.50

Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemp Clin Trials (2009) 1.48

Prevalence of HBV precore/core promoter variants in the United States. Hepatology (2003) 1.47

Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transpl (2011) 1.44

Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology (2004) 1.39

Ascites: diagnosis and management. Med Clin North Am (2009) 1.37

Drug-induced steatohepatitis. Clin Liver Dis (2003) 1.36

A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans. Clin Gastroenterol Hepatol (2004) 1.33

Endoplasmic reticulum stress and the unfolded protein response. Clin Liver Dis (2009) 1.28

Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology (2008) 1.24

Compliance with practice guidelines and risk of a first esophageal variceal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 1.23

Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis (2004) 1.22

Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology (2008) 1.21

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol (2009) 1.21

Portal hypertension and variceal hemorrhage. Med Clin North Am (2008) 1.19

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol (2010) 1.17

The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol (2002) 1.16

The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol (2002) 1.16

Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet (2005) 1.16

Hepatitis C and nonalcoholic fatty liver disease. Semin Liver Dis (2004) 1.15

HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells. Gastroenterology (2009) 1.15

Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol (2009) 1.14

Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol (2009) 1.13

A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology (2011) 1.12

Clinical aspects of fatty liver disease. Semin Liver Dis (2004) 1.11

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology (2013) 1.10

Recent advances in nonalcholic fatty liver disease. Curr Opin Gastroenterol (2008) 1.10

Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C. Am J Gastroenterol (2005) 1.09

Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response? Am J Gastroenterol (2004) 1.08

Evaluation and management of non-alcoholic steatohepatitis. J Hepatol (2004) 1.07

The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol (2009) 1.06